Thrombopoietin receptor agonists in immune thrombocytopenia of less than 6 months duration.

Arumugaswamy, A; He, S; Quach, H; Brotchie, J; Grigg, A

Arumugaswamy, A; He, S; Quach, H; Brotchie, J; Grigg, A.

Affiliation

Arumugaswamy A; Department of Haematology, Austin Hospital, Melbourne, Victoria, Australia.

Intern Med J ; 44(5): 519-21, 2014 May.

Article in En | MEDLINE | ID: mdl-24816314

Subject(s)

Benzoates/therapeutic use; Hydrazines/therapeutic use; Purpura, Thrombocytopenic, Idiopathic/drug therapy; Pyrazoles/therapeutic use; Receptors, Fc/therapeutic use; Receptors, Thrombopoietin/agonists; Recombinant Fusion Proteins/therapeutic use; Thrombopoietin/therapeutic use; Aged; Drug Evaluation; Drug Therapy, Combination; Female; HIV Infections/complications; Hepatitis C/complications; Humans; Immunosuppressive Agents/therapeutic use; Male; Middle Aged; Platelet Count; Prednisolone/therapeutic use; Purpura, Thrombocytopenic, Idiopathic/etiology; Time Factors

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrazoles / Thrombopoietin / Benzoates / Recombinant Fusion Proteins / Receptors, Fc / Purpura, Thrombocytopenic, Idiopathic / Receptors, Thrombopoietin / Hydrazines Type of study: Etiology_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Intern Med J Year: 2014 Document type: Article

Fulltext

XML

PubMed Links

Search on Google